Anthea Pharma vs Scinai Immunotherapeutics Ltd.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/antheapharma/scinai-immunotherapeutics

Category	Anthea Pharma	Scinai Immunotherapeutics Ltd.
Listed site	both	both
Summary	Anthea Pharma is an injectable CDMO in Hyderabad, India, offering development and manufacturing of vials, emulsions, lyophilized vials, and prefilled syringes. The company highlights aseptic fill and finish, terminal sterilization, lyophilization, and formulation and analytical development for clients.	Boutique biologics CDMO providing analytical method development, process development, and cGMP manufacturing for biotech clients from early research through Phase 3, backed by over 20 years of experience and state-of-the-art facilities.
Services	Formulation Development CMC Analytical Development Lyophilization (Freeze Drying) Vial Filling Sterile Fill-Finish & Aseptic Manufacturing Prefilled Syringe (PFS) Filling Technology Transfer Process Development Quality Control Testing	CMC Analytical Development Process Development CMC Regulatory Submission Support Technology Transfer Recombinant Protein Manufacturing Biologics Development & Manufacturing
Modalities	Data not yet provided.	Biologics (Monoclonal Antibodies)
Indications	Data not yet provided.	Dermatology Immunology Rare Disease
Locations	Hyderabad, Hyderabad, Telangana, India	Headquarters, Jerusalem, Israel Yavne CDMO Facility, Yavne, Israel
Certifications	Data not yet provided.	EMA · Identifier: European QP (EMA) audit passed Israeli Ministry of Health · Identifier: Israeli MoH audit passed for Phase 3 clinical trial production
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.